Yoshiko Asai

No ORCID on file · 1 paper in corpus
other 2022
The novel oral gonadotropin-releasing hormone receptor antagonist relugolix is a new option for controlled ovarian stimulation cycles
Reproductive medicine and biology ·doi:10.1002/rmb2.12448

PURPOSE: Relugolix is an oral gonadotropin-releasing hormone antagonist (GnRHant), which was first introduced in 2019. This study investigated the effects of the conventional injectable GnRHant formulation and this new oral GnRHant formulat…